Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Effects of a Three Week Treadmill Versus Cycling Endurance Training on Balance, Gait Performance and Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease - a Pilot Study
Verified date | February 2018 |
Source | Klinikum Berchtesgadener Land der Schön-Kliniken |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Aim of this study is to investigate the effects of treadmill versus cycling endurance
training on Balance, gait performance and exercise capacity in patients with severe chronic
obstructive pulmonary disease. Patients will be recruited during a 3-week inpatient pulmonary
rehabilitation program and will be randomized into one of two intervention groups. Walking
intensity in the treadmill group will be set at 80 percent of the average speed of the
6-minute walking test. The cycling group will exercise at an intensity of 60 percent
according to an Initial incremental cycling test.
Patients will perform 5 to 6 training sessions per week. The total exercise duration will be
progressively increased from 10 to 30 minutes. Walking or cycling intensity will also be
progressively increased if perceived exertion during exercise is rated below 3 on the
modified 10-point Borg scale.
Status | Completed |
Enrollment | 30 |
Est. completion date | November 27, 2017 |
Est. primary completion date | November 27, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years to 80 Years |
Eligibility |
Inclusion Criteria: - COPD Stage III or IV according to the global initiative for chronic obstructive lung disease - impaired exercise capacity (6 Minute walk distance of less than 70% of the reference values from Troosters et al.) Exclusion Criteria: - acute, severe exacerbation of COPD - carbon dioxide of more than 45 mmHg at rest - any disabilities that prevent patient form walking or cycling - Patient is not able to walk 20 meters without any aid (for example rollator) |
Country | Name | City | State |
---|---|---|---|
Germany | Schoen Klinik Berchtesgadener Land | Schoenau Am Koenigssee |
Lead Sponsor | Collaborator |
---|---|
Klinikum Berchtesgadener Land der Schön-Kliniken |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in step symmetry during 20m walking | Patients walk 20m while wearing the Mc Roberts move test device (triaxial accelerometer) which performs a gait analysis | measurement on day 1 and 21 | |
Secondary | Change in balance performance during semi-tandem stance | patients stand still for 10 seconds on a force platform that measures absolute path length of the center of force. | measurement on day 1 and 21 | |
Secondary | Change in balance performance during Romberg stance | patients stand still for 10 seconds on a force platform that measures absolute path length of the center of force. | measurement on day 1 and 21 | |
Secondary | Change in balance performance during single leg stance | patients stand still for 10 seconds on a force platform that measures absolute path length of the center of force. | measurement on day 1 and 21 | |
Secondary | Change in muscle power during counter movement jump | patients jump on a force platform as high as possible. The Outcome is Watt per Kilogram Body weight | measurement on day 1 and 21 | |
Secondary | Change in 1 Minute sit to stand test | Patients try to perform as many repetitions as possible of standing up and sitting down from a chair with crossed arms on a force platform during 1 minute | measurement on day 1 and 21 | |
Secondary | Change in 5 Repetition sit to stand test | Patients try to perform 5 repetitions of standing up and sitting down from a chair with crossed arms on a force platform as quick as possible | measurement on day 1 and 21 | |
Secondary | Change in peak muscle strength | isometric peak torque of the knee extensor muscles are measured in 90° knee angle | measurement on day 1 and 21 | |
Secondary | Change in 4 meter gait Speed test | patients have to walk 4 meters at their usual Speed. Outcome is the average Speed during the 4m walk. | measurement on day 1 and 21 | |
Secondary | Change in 6-minute Walk test | the best out of two 6- Minute Walk Tests will be used for analysis | measurement on day 1 and 21 | |
Secondary | Change in Hospital anxiety and Depression scale | the Hospital anxiety and Depression scale is a questionnaire that evaluates signs of anxiety or depression | measurement on day 1 and 21 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|